Foresight Institute Radio cover image

Nir Barzilai | Targeting Aging with Metformin

Foresight Institute Radio

00:00

Introduction

Neobazilai: We're trying to see which other FDA-approved drugs can be used immediately in a clinical trial based on a neuroscience guided approach. He says the bottom line of neuroscience is that when you target one of those hallmarks, you affect others. The short Taim trial serves as a data springboard for the whole longevity field and may move the FDA closer to accepting clinical trials that target mechanisms of aging rather than specific named age-related condition.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app